GSE195518
TREM2 Drives Microglia Response to Amyloid-ß via SYK-dependent and -independent Paths [SYK and TREM2 scRNA-seq]
Genetic studies have highlighted microglia as pivotal in orchestrating Alzheimer's disease (AD). Microglia that adhere to Aß plaques acquire a transcriptional signature, “diseaseassociated microglia” (DAM), which largely emanates from the TREM2-DAP12 receptor complex that transmits intracellular signals through the protein tyrosine kinase SYK. The human TREM2R47H variant associated with high AD risk fails to activate microglia via SYK. We found that SYK-deficient microglia cannot encase Aß plaques, accelerating brain pathology and behavioral deficits. SYK deficiency impaired the PI3K-AKT-GSK3ß-mTOR pathway, incapacitating anabolic support required for attaining the DAM profile. However, SYK-deficient microglia proliferated and advanced to an Apoe-expressing prodromal stage of DAM; this pathway relied on the adaptor DAP10, which also binds TREM2. Thus, microglial responses to Aß involve non-redundant SYK- and DAP10-pathways. Systemic administration of an antibody against CLEC7A, a receptor that directly activates SYK, rescued microglia activation in mice expressing the TREM2R47H allele, unveiling new options for AD immunotherapy. Overall design: 6-month old female 3 Syk fl/fl, 3 Cx3cr1-creER Syk fl/fl, 3 Syk fl/fl 5XFAD, 3 Cx3cr1-creER Syk fl/fl 5XFAD mice, 2 Trem2 WT 5XFAD, and 3 Trem2 KO 5XFAD mice.